About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT04211636

Autoimmunity And Immune Deficiency After Spinal Cord Injury: Association With Rehabilitation Outcomes

The SCIentinel-prolong study systematically analyzes humoral autoantibody responses and thier interaction with post-spinal cord injury (SCI) immune-deficiency and infections as well as their associati...

Lead sponsor: Marcel Kopp, MD•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Marcel A Kopp, MD

CONTACT

+49 30 450560075 marcel.kopp@charite.de

Christian Blex, PhD

CONTACT

+49 30 450560075 christian.blex@charite.de

Sponsors

Lead Sponsor

Marcel Kopp, MD

Collaborators

Foundation Wings For Life
University Hospital Tuebingen
Unfallkrankenhaus Berlin
Balgrist University Hospital
I.R.C.C.S. Fondazione Santa Lucia
University of Zurich
Medical University of Vienna
Ruhr University of Bochum
Swiss Federal Institute of Technology
King's College London
McGill University Health Centre/Research Institute of the McGill University Health Centre
Ohio State University

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Acute traumatic SCI, American Spinal Injury Association Impairment Scale (AIS) A to D, neurologic level of injury C3 - L2 or acute vertebral fracture without SCI
•Inclusion within 21 days post-injury
•For Italian centers only: SCI-Treatment using Methylprednisolone (according to NASCIS).

Exclusion Criteria

•Non-traumatic SCI
•Severe multiple trauma
•Serious traumatic brain injury
•Pre-exiting neurological diseases
•Malignant Neoplasia, except in complete remission for 5 years
•Rheumatic diseases / collagenosis / vasculitis
•Other autoimmune diseases
•Pre-existing chronic infection
•Severe alcohol or drug addiction
•Pregnancy or lactation
•Simultaneous participation in interventional clinical trials
•For centers in Germany or Switzerland only: SCI-treatment using Methylprednisolone (according to NASCIS).

Related studies

Spinal Cord Stimulation (SCS) for Spinal Cord Injury (SCI)

NCT04894734 · Spinal Cord Injury at T1-T12 Level, Traumatic Thoracic Spinal Cord Contusion, and more

RECRUITINGPhase 2

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

NCT04460872 · Spinal Cord Injury, Spinal Cord Injuries, and more

Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia

NCT04378218 · Paraplegia, Spinal, Spinal Cord Trauma

COMPLETEDPhase 1/2

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

NCT02302157 · Cervical Spinal Cord Injury, Spine Injury, and more

COMPLETEDPhase 4

A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction

NCT00654082 · Spinal Cord Injury, Erectile Dysfunction, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 8, 2023Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment81

Start dateOct 2023

Last updatedFeb 8, 2023

Condition

Spinal Cord Trauma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 8, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions